G

GH Research PLC
NASDAQ:GHRS

Watchlist Manager
GH Research PLC
NASDAQ:GHRS
Watchlist
Price: 9.24 USD 0.98% Market Closed
Market Cap: 480.8m USD
Have any thoughts about
GH Research PLC?
Write Note

Relative Value

There is not enough data to reliably calculate the relative value of GHRS.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

GHRS Relative Value
Base Case
Not Available
G
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.6
vs History
vs Industry
Median 3Y
-21.9
Median 5Y
-22.4
Industry
23
Forward
-10.7
vs History
vs Industry
Median 3Y
-20.6
Median 5Y
-20.7
Industry
17.8
vs History
vs Industry
Median 3Y
-20.6
Median 5Y
-20.6
Industry
25.4
vs History
55
vs Industry
30
Median 3Y
2.3
Median 5Y
2.4
Industry
2.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
2.8
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.4
vs History
vs Industry
Median 3Y
-11.7
Median 5Y
-11.8
Industry
13.7
Forward
-6.5
vs History
vs Industry
Median 3Y
-11.6
Median 5Y
-11.7
Industry
17.2
Forward
-6.2
vs History
vs Industry
Median 3Y
-12.9
Median 5Y
-12.9
Industry
16.5
vs History
vs Industry
Median 3Y
-12.9
Median 5Y
-12.9
Industry
19.3
vs History
41
vs Industry
13
Median 3Y
5.3
Median 5Y
5.2
Industry
2

Multiples Across Competitors

GHRS Competitors Multiples
GH Research PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IE
GH Research PLC
NASDAQ:GHRS
480.7m USD 0 -17.6 -9.8 -9.7
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
771.1B USD 18.9 92.1 49.5 55.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35.3 24.5 28
US
Johnson & Johnson
NYSE:JNJ
368.9B USD 4.2 25.1 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
249.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
209.8B CHF 3.6 18.2 10.3 12.2
CH
Novartis AG
SIX:NOVN
179.9B CHF 4.2 12.6 10 14.8
UK
AstraZeneca PLC
LSE:AZN
157.3B GBP 4.1 31 169.2 253.5
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
IE
G
GH Research PLC
NASDAQ:GHRS
Average P/E: 33.6
Negative Multiple: -17.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
92.1
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35.3
86%
US
Johnson & Johnson
NYSE:JNJ
25.1
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top